mitoxantrone has been researched along with Ambulation Disorders, Neurologic in 2 studies
Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kale, N | 1 |
| Icen, M | 1 |
| Agaoglu, J | 1 |
| Yazici, I | 1 |
| Tanik, O | 1 |
| Berger, JR | 1 |
1 review available for mitoxantrone and Ambulation Disorders, Neurologic
| Article | Year |
|---|---|
Functional improvement and symptom management in multiple sclerosis: clinical efficacy of current therapies.
Topics: Activities of Daily Living; Adrenal Cortex Hormones; Antibodies, Monoclonal, Humanized; Antineoplast | 2011 |
1 other study available for mitoxantrone and Ambulation Disorders, Neurologic
| Article | Year |
|---|---|
Clustering of organ-specific autoimmunity: a case presentation of multiple sclerosis and connective tissue disorders.
Topics: Activities of Daily Living; Autoimmune Diseases; Autoimmunity; Brain; Cluster Analysis; Connective T | 2008 |